These approvals were based on Phase 3 data demonstrating a statistically significant and clinically meaningful reduction of weight and hunger in patients 12 years old or older with severe obesity due to POMC, PCSK1 or LEPR deficiency
Theyre made by the same company, they contain the same drug, they come as daily tablets, and they even use the same absorption technology
Early studies suggest that Retatrutide could achieve greater weight reduction and broader metabolic benefits at lower relative exposure compared with Tirzepatide, although phase 3 trials are ongoing to confirm these findings
Ask them to call 1-833-949-5527, Monday-Friday, 9 am-5 pm ET
Diabetes 51 , 35323544 (2002)
Modern bariatric procedures are minimally invasive and performed with advanced laparoscopic techniques at NObesity, ensuring safety, precision, and faster recovery